Resmed Names Salli Schwartz as Chief Investor Relations Officer
SAN DIEGO, April 21, 2025 — Resmed (NYSE: RMD, ASX: RMD), a global leader in health technology focused on sleep, breathing, and home care, has appointed Salli Schwartz as Chief Investor Relations Officer, effective April 21, 2025. Schwartz will lead Resmed’s global investor relations function and report to Mick Farrell, Chairman of the Board and CEO.
Schwartz brings more than two decades of experience in finance roles at health tech and financial services organizations. Most recently, she served as Head of Investor Relations at Illumina, Inc., where she led the company’s investor engagement strategy and represented the company’s response to shareholders’ perspectives on corporate strategy, capital allocation, and financial performance. She was also a member of Illumina’s Corporate Social Responsibility Executive Steering Committee and its Transformation Office.
“Salli is a seasoned financial leader with a proven track record of driving investor relationships supporting business strategy and capital efficiency,” said Farrell. “Her leadership and expertise will be critical as we advance our 2030 strategy to drive shareholder value and empower 500 million people worldwide to achieve their full health potential.”
Prior to Illumina, Schwartz served as Head of Investor Relations and Treasurer at MSCI, Inc., managing investor communications and a significant investment portfolio. She held multiple roles at Moody’s Corporation, including Global Head of Strategic Capital Management and Treasurer, and Global Head of Investor Relations and Communications. Schwartz also worked in corporate strategy, corporate treasury, and FP&A with Citigroup Inc.
“I am excited to join Resmed at such a pivotal moment in its strategy to make better sleep and breathing health more accessible around the world,” said Schwartz. “I look forward to partnering with our leadership team and our shareholders to communicate and advance Resmed’s vision and financial targets.”
Resmed creates life-changing health technologies that empower millions of people in 140 countries to live happier, healthier lives. The company’s AI-powered digital health solutions, cloud-connected devices, and intelligent software make home healthcare more personalized, accessible, and effective. Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home.
